Molecular biology of osteosarcoma

AM Czarnecka, K Synoradzki, W Firlej, E Bartnik… - Cancers, 2020 - mdpi.com
Osteosarcoma (OS) is the most frequent primary bone cancer in children and adolescents
and the third most frequent in adults. Many inherited germline mutations are responsible for …

Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models

C Ceci, MG Atzori, PM Lacal, G Graziani - International journal of …, 2020 - mdpi.com
The vascular endothelial growth factor (VEGF) family members, VEGF-A, placenta growth
factor (PlGF), and to a lesser extent VEGF-B, play an essential role in tumor-associated …

2D MXeneintegrated 3Dprinting scaffolds for augmented osteosarcoma phototherapy and accelerated tissue reconstruction

S Pan, J Yin, L Yu, C Zhang, Y Zhu, Y Gao… - Advanced …, 2020 - Wiley Online Library
The residual of malignant tumor cells and lack of bonetissue integration are the two critical
concerns of bonetumor recurrence and surgical failure. In this work, the rational integration …

[HTML][HTML] Fundamentals of bone vasculature: Specialization, interactions and functions

C Owen-Woods, A Kusumbe - Seminars in cell & developmental biology, 2022 - Elsevier
Angiogenesis, hematopoiesis and osteogenesis are fundamental processes mediating
complex and essential biological functions. In the bone marrow, endothelial cells (ECs) are …

miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2

X Sun, G Dai, L Yu, Q Hu, J Chen, W Guo - Scientific reports, 2018 - nature.com
Osteosarcoma (OS) is the most common type of primary malignant bone tumor and mainly
occurs in children and adolescent. Because of its early migration and invasion, OS has a …

Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer

S Girisa, S Henamayee, D Parama, V Rana… - Molecular …, 2021 - Springer
Cancer is one of the lethal diseases that arise due to the molecular alterations in the cell.
One of those alterations associated with cancer corresponds to differential expression of …

Osteosarcoma, chondrosarcoma and Ewing sarcoma: Clinical aspects, biomarker discovery and liquid biopsy

V Aran, S Devalle, W Meohas, M Heringer… - Critical Reviews in …, 2021 - Elsevier
Bone sarcomas, although rare, are associated with significant morbidity and mortality. The
most frequent primary bone cancers include osteosarcoma, chondrosarcoma and Ewing …

[HTML][HTML] Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma …

LM Kopp, S Malempati, M Krailo, Y Gao… - European Journal of …, 2019 - Elsevier
Background The prognosis is poor for children and adolescents with recurrent
osteosarcoma (OS). Glycoprotein non-metastatic B (gpNMB) is a glycoprotein highly …

Unraveling molecular signatures in rare bone tumors and navigating the cancer pathway landscapes for targeted therapeutics

AK Wani, A Prakash, S Sena, N Akhtar, R Singh… - Critical Reviews in …, 2024 - Elsevier
Rare cancers (RCs), which account for over 20% of cancer cases, face significant research
and treatment challenges due to their limited prevalence. This results in suboptimal …

[HTML][HTML] Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis

Z Wang, G Chen, X Chen, X Huang, M Liu… - Journal of …, 2019 - ncbi.nlm.nih.gov
Purpose: Chondrosarcoma with metastatic disease has a very poor prognosis. However, the
prognosis and potential prognostic factors of patients with primary chondrosarcoma of bone …